VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
RNAZTransCode Therapeutics, Inc.
$5.00$5M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksRNAZPrice History

RNAZ logoTransCode Therapeutics, Inc. (RNAZ) Stock Price History

Historical prices from 2021 to 2026

$5.00+0.30  (+6.38%)close Jun 22
Returns
1M
-23.8%
3M
-50.0%
YTD
-36.5%
1Y
-32.7%
3Y
-95.9%
5Y
-91.4%
ATH$999,999.00Jun 2022-100.0%
ATL$3.85Jun 2026pre-split
Avg Vol (50D)62K/ day
52-Week Range$3.85 — $20.99
LowCurrent: $5.00High

Loading 10-year price history...

RNAZ Historical Performance

1 YearTotal Return
-32.7%
Price: -32.7%
3 YearsTotal Return
-100.0%
CAGR: -95.9%
Price: -100.0%
5 YearsTotal Return
-100.0%
CAGR: -91.3%
Price: -100.0%
YTD
-36.5%

RNAZ Annual Returns

Year-by-year price performance · 2021–2026

Best+0.0%2021
Worst-98.7%2023
Up years2/6
2021+0.0%
2022-65.2%
2023-98.7%
2024-98.4%
2025-90.1%
2026+29.9%
2021 annual price return
+0.0%
2022 annual price return
-65.2%
2023 annual price return
-98.7%
2024 annual price return
-98.4%
2025 annual price return
-90.1%
2026 annual price return
+29.9%
LessMore
Alpha vs S&P 500
1Y-57.7%
3Y-115.3%
5Y-103.8%

Price returns only.

Download Historical Data

1,244 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

RNAZ Stock Price Trajectory (2021–2026)

As of June 23, 2026, TransCode Therapeutics, Inc. (RNAZ) trades at $5.00, representing a -32.7% return over the past year. The stock has delivered a -100.0% total return over five years (-91.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $999,999.00 on June 7, 2022. From this peak, RNAZ has corrected -100.0%, currently trading 45% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ARWR (+423.8% 1Y), NTLA (+63.2% 1Y), and SRPT (-15.6% 1Y), RNAZ has underperformed the peer group average. Compare RNAZ vs ARWR →

RNAZ Historical Price Data · from 2021

Rows 1–50 of 1,244
Date Open High Low Close Volume Change %
2026-06-224.705.184.355.0012K+6.38%
2026-06-185.295.454.704.7031K-12.15%
2026-06-175.305.875.095.3521K-3.43%
2026-06-165.475.645.415.5412K+1.28%
2026-06-155.176.005.025.4738K+2.63%
2026-06-125.435.505.305.336K-6.33%
2026-06-115.275.825.175.698K+3.27%
2026-06-105.175.584.575.5118K+10.64%
2026-06-095.005.204.874.9820K+6.41%
2026-06-085.545.684.594.6883K-16.43%
2026-06-055.766.305.525.60754-4.11%
2026-06-045.075.994.705.84129K+15.87%
2026-06-034.255.223.855.042.32M-4.64%
2026-06-025.455.595.145.2916K-2.76%
2026-06-015.385.755.255.4410K+2.36%
2026-05-295.455.465.125.318K+0.38%
2026-05-285.115.705.115.2920K+3.93%
2026-05-275.205.935.015.0920K-5.57%
2026-05-265.435.815.055.3937K-13.62%
2026-05-226.046.556.036.246K+2.04%
2026-05-216.016.126.006.125K+0.08%
2026-05-206.006.275.566.1115K-1.10%
2026-05-196.356.506.016.1812K+0.13%
2026-05-186.647.146.026.1710K-6.51%
2026-05-156.997.226.566.606K-2.78%
2026-05-147.107.436.776.799K-2.60%
2026-05-136.867.446.706.9711K+3.57%
2026-05-127.047.046.666.736K-3.86%
2026-05-117.017.486.507.0024K-4.37%
2026-05-087.508.017.277.327K-8.50%
2026-05-077.508.257.488.0011K+6.38%
2026-05-067.887.907.517.528K-4.33%
2026-05-058.018.087.867.865K+1.55%
2026-05-047.928.217.747.746K-1.15%
2026-05-017.998.407.837.835K-2.25%
2026-04-308.369.308.018.0110K-4.64%
2026-04-298.548.548.168.4010K-0.59%
2026-04-288.308.628.248.451K+1.68%
2026-04-278.708.798.308.312K-2.46%
2026-04-248.488.698.348.521K-1.73%
2026-04-239.109.108.558.675K+0.85%
2026-04-228.598.788.458.605K-3.07%
2026-04-218.658.878.658.871K-0.17%
2026-04-208.798.968.618.883K+0.97%
2026-04-179.009.008.618.804K+1.15%
2026-04-168.699.518.678.709K-2.36%
2026-04-158.909.158.558.916K+0.11%
2026-04-149.809.948.908.9020K+1.14%
2026-04-137.928.807.888.806K+7.19%
2026-04-108.218.508.218.2111K-3.98%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

RNAZ — Frequently Asked Questions

Quick answers to the most common questions about buying RNAZ stock.

How has RNAZ stock performed recently?

RNAZ declined -32.7% over the past year, below its 5-year annualized CAGR of -91.4%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is RNAZ's all-time high price?

TransCode Therapeutics, Inc. reached $999999.00 on 2022-06-07. The 52-week high is $20.99. Current 1-year return of -32.7% places the stock further from historical peaks.

Where can I download RNAZ historical price data?

This page provides RNAZ daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

416 data points · sampled from 1,244